Quantum Biopharma Ltd..
QNTM.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Quantum Biopharma Ltd. is a biopharmaceutical company focused on the research, development, and commercialization of novel therapies. While specific details about their therapeutic areas and product pipeline are not available in this context, the company's core activity revolves around creating and ...Show More
Better Health for All
40
Quantum BioPharma's core business is focused on developing novel therapies for serious conditions such as multiple sclerosis, nociplastic pain in MCAS, and alcohol misuse, indicating that 100% of its product pipeline is aimed at delivering revolutionary health benefits.
1
The company has no products with significant negative health impacts, as its offerings are designed to be health-positive or harm-mitigating.
2
Furthermore, Quantum BioPharma received Human Research Ethics Committee (HREC) approval in Australia for a Phase 2 clinical trial, demonstrating adherence to strong ethical standards for clinical trials.
3
Fair Money & Economic Opportunity
0
The provided article is a placeholder and explicitly states that it does not contain any data relevant to QNTM.US or the ethical value of Fair Money & Economic Opportunity.
1
No quantitative data, regulatory actions, certifications, comparisons, or contradictions were found, therefore no assessment can be made against the specified KPIs.
2
Fair Pay & Worker Respect
0
No evidence available to assess Quantum Biopharma Ltd. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No quantitative data is available across any of the KPIs for Fair Trade & Ethical Sourcing. While several articles mention Quantum's Business Partner Code of Conduct
1
and Supplier Code of Conduct
2
, which cover aspects like compliance with labor laws, environmental regulations, anti-corruption, and conflict minerals
3
, these documents outline expectations and policies rather than providing specific performance metrics. For example, ethical sourcing clauses are required in contracts, and conflict minerals reports are mentioned, but no percentages for coverage or spend are provided.
4
Similarly, the company conducts regular visits to key supplier facilities but explicitly states it does not use third-party, unannounced audits, and no frequency for these visits is specified.
5
There is no information on fair trade certifications, forced or child labor incidents, supply chain traceability, remediation speed for violations, or supplier diversity spend.
6
Honest & Fair Business
-40
Quantum Biopharma Ltd. has a formal whistle-blower policy that includes reporting channels such as dedicated email addresses and EthicsPoint.
1
However, the provided information does not include details on protection mechanisms, hotline statistics, or evidence of independent investigation processes.
2
The company also has a comprehensive anti-corruption policy that prohibits bribery, gifts, and payments to government officials, covering various international anti-corruption laws.
3
This policy includes due diligence procedures, record-keeping, and reporting mechanisms, but specific enforcement details or metrics on training frequency and effectiveness are not provided.
4
Kind to Animals
-50
Quantum Biopharma Ltd. conducts preclinical studies on animals to assess product safety, as stated on its website, and uses preclinical models to test Lucid-MS.
1
The company completed dosing in 180-day repeated dose oral toxicity and toxicokinetic studies for Lucid-MS in December 2025.
2
Lucid-MS has shown results in several animal models over more than 11 years of research and development, with one video example taken from a large cohort of mice in experiments conducted across multiple labs over several years.
3
The company is preparing an Investigational New Drug (IND) application with the FDA.
4
No War, No Weapons
0
No evidence available to assess Quantum Biopharma Ltd. on No War, No Weapons.
Planet-Friendly Business
0
No data relevant to the Planet-Friendly Business KPIs was found in the provided articles. The press release explicitly states it does not contain any data for environmental, social, and governance factors, and the SEC filing could not be accessed to extract information.
1
Respect for Cultures & Communities
0
No evidence available to assess Quantum Biopharma Ltd. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Quantum Biopharma Ltd. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles regarding Quantum Biopharma Ltd.'s performance on any of the Zero Waste & Sustainable Products KPIs.
1
All articles were placeholders and explicitly stated a lack of relevant information, including quantitative data, regulatory actions, certifications, awards, or comparisons to industry benchmarks.
2